Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Quadropril
2. Renormax
3. Renpress
4. Sch 33844
5. Sch-33844
6. Spirapril
1. Spirapril Hcl
2. 94841-17-5
3. Spirapril Hydrochloride [usan]
4. Sch 33844
5. Occ25lm897
6. 83647-97-6 (free Base)
7. (8s)-7((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)-1,4-dithia-7-azaspiro(4.4)nonane-8-carboxylic Acid, 1-ethyl Ester, Monohydrochloride
8. Sch-33844
9. (8s)-7-[(2s)-2-[[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic Acid;hydrochloride
10. 1,4-dithia-7-azaspiro(4.4)nonane-8-carboxylic Acid, 7-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, Monohydrochloride, (8s-(7(r*(r*)),8r*))-
11. Spirapril Hydrochloride (usan)
12. (s)-7-(((s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-l-alanyl)-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic Acid Hydrochloride
13. Unii-occ25lm897
14. Renormax (tn)
15. Spiraprilhydrochloride
16. Ncgc00182545-01
17. Dsstox_cid_24272
18. Dsstox_rid_80139
19. Dsstox_gsid_44272
20. Schembl387353
21. Spirapril For System Suitability
22. Chembl1200831
23. Dtxsid6044272
24. Spirapril Hydrochloride [mi]
25. Tox21_112981
26. Akos025311425
27. Spirapril Hydrochloride [mart.]
28. Spirapril Hydrochloride [vandf]
29. Spirapril Hydrochloride [who-dd]
30. Cas-94841-17-5
31. Spirapril Hydrochloride [orange Book]
32. D03765
33. A854716
34. Q27285573
35. (8s)-7-[(2s)-2-[[(1s)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic Acid Monohydrochloride
36. 1,4-dithia-7-azaspiro(4.4)nonane-8-carboxylic Acid, 7-((2s)-2-(((1s)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, Hydrochloride (1:1), (8s)-
| Molecular Weight | 503.1 g/mol |
|---|---|
| Molecular Formula | C22H31ClN2O5S2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 10 |
| Exact Mass | 502.1362921 g/mol |
| Monoisotopic Mass | 502.1362921 g/mol |
| Topological Polar Surface Area | 147 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 650 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Angiotensin-Converting Enzyme Inhibitors
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
ABOUT THIS PAGE
55
PharmaCompass offers a list of Spirapril API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Spirapril manufacturer or Spirapril supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Spirapril manufacturer or Spirapril supplier.
PharmaCompass also assists you with knowing the Spirapril API Price utilized in the formulation of products. Spirapril API Price is not always fixed or binding as the Spirapril Price is obtained through a variety of data sources. The Spirapril Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Spirapril manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Spirapril, including repackagers and relabelers. The FDA regulates Spirapril manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Spirapril API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Spirapril supplier is an individual or a company that provides Spirapril active pharmaceutical ingredient (API) or Spirapril finished formulations upon request. The Spirapril suppliers may include Spirapril API manufacturers, exporters, distributors and traders.
Spirapril Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Spirapril GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Spirapril GMP manufacturer or Spirapril GMP API supplier for your needs.
A Spirapril CoA (Certificate of Analysis) is a formal document that attests to Spirapril's compliance with Spirapril specifications and serves as a tool for batch-level quality control.
Spirapril CoA mostly includes findings from lab analyses of a specific batch. For each Spirapril CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Spirapril may be tested according to a variety of international standards, such as European Pharmacopoeia (Spirapril EP), Spirapril JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Spirapril USP).
